These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 10071314)

  • 1. Helicobacter pylori eradication treatment reduces the severity of rosacea.
    Utaş S; Ozbakir O; Turasan A; Utaş C
    J Am Acad Dermatol; 1999 Mar; 40(3):433-5. PubMed ID: 10071314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of bismuth addition to sequential treatment on Helicobacter pylori eradication: A pilot study.
    Basyigit S; Kefeli A; Sapmaz F; Yeniova AO; Asilturk Z; Hokkaomeroglu M; Uzman M; Nazligul Y
    Bosn J Basic Med Sci; 2015 Oct; 15(4):50-4. PubMed ID: 26614852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bismuth-based therapies for the first step eradication of Helicobacter pylori.
    Sezgin O; Altintaş E; Uçbilek E; Tataroğlu C
    Turk J Gastroenterol; 2006 Jun; 17(2):90-3. PubMed ID: 16830288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The seroprevalence of Helicobacter pylori and nitric oxide in acne rosacea.
    Gürer MA; Erel A; Erbaş D; Cağlar K; Atahan C
    Int J Dermatol; 2002 Nov; 41(11):768-70. PubMed ID: 12452999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of sequential therapy and amoxicillin/tetracycline containing bismuth quadruple therapy for the first-line eradication of Helicobacter pylori: a prospective, multi-center, randomized clinical trial.
    Lee JY; Kim N; Park KS; Kim HJ; Park SM; Baik GH; Shim KN; Oh JH; Choi SC; Kim SE; Kim WH; Park SY; Kim GH; Lee BE; Jo Y; Hong SJ
    BMC Gastroenterol; 2016 Jul; 16(1):79. PubMed ID: 27460100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial.
    Liou JM; Fang YJ; Chen CC; Bair MJ; Chang CY; Lee YC; Chen MJ; Chen CC; Tseng CH; Hsu YC; Lee JY; Yang TH; Luo JC; Chang CC; Chen CY; Chen PY; Shun CT; Hsu WF; Hu WH; Chen YN; Sheu BS; Lin JT; Wu JY; El-Omar EM; Wu MS;
    Lancet; 2016 Nov; 388(10058):2355-2365. PubMed ID: 27769562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between Helicobacter pylori and rosacea: it may be a myth.
    Herr H; You CH
    J Korean Med Sci; 2000 Oct; 15(5):551-4. PubMed ID: 11068993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of 10-day levofloxacin bismuth-based quadruple therapy and levofloxacin-based triple therapy for Helicobacter pylori.
    Wu TS; Hsu PI; Kuo CH; Hu HM; Wu IC; Wang SSW; Chen YH; Wu DC; Su WW; Kuo FC
    J Dig Dis; 2017 Sep; 18(9):537-542. PubMed ID: 28644575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seven-Day Bismuth-based Quadruple Therapy as an Initial Treatment for Helicobacter pylori Infection in a High Metronidazole Resistant Area.
    Vilaichone RK; Prapitpaiboon H; Gamnarai P; Namtanee J; Wongcha-um A; Chaithongrat S; Mahachai V
    Asian Pac J Cancer Prev; 2015; 16(14):6089-92. PubMed ID: 26320500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Helicobacter pylori: related to rosacea?
    Grilli R
    J Am Acad Dermatol; 2000 Mar; 42(3):536-7. PubMed ID: 10688738
    [No Abstract]   [Full Text] [Related]  

  • 11. Helicobacter pylori infection in recurrent abdominal pain in childhood: comparison of diagnostic tests and therapy.
    Chong SK; Lou Q; Asnicar MA; Zimmerman SE; Croffie JM; Lee CH; Fitzgerald JF
    Pediatrics; 1995 Aug; 96(2 Pt 1):211-5. PubMed ID: 7630671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological effects of metronidazole+tetracycline+bismuth subcitrate versus omeprazole+amoxycillin+bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease.
    Park KN; Hahm JS; Kim HJ
    Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S103-7. PubMed ID: 7735924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic success with bismuth-containing sequential and quadruple regimens in Helicobacter pylori eradication.
    Ozturk O; Doganay L; Colak Y; Yilmaz Enc F; Ulasoglu C; Ozdil K; Tuncer I
    Arab J Gastroenterol; 2017 Jun; 18(2):62-67. PubMed ID: 28601610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ranitidine versus colloidal bismuth subcitrate in combination with amoxicillin and metronidazole for eradicating Helicobacter pylori in patients with duodenal ulcer.
    Carpintero P; Blanco M; Pajares JM
    Clin Infect Dis; 1997 Nov; 25(5):1032-7. PubMed ID: 9402352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survey of anaemia and Helicobacter pylori infection in adolescent girls in Suihua, China and enhancement of iron intervention effects by H. pylori eradication.
    Xia W; Zhang X; Wang J; Sun C; Wu L
    Br J Nutr; 2012 Jul; 108(2):357-62. PubMed ID: 22004585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of culture results for Helicobacter pylori on the choice of treatment following failure of initial eradication.
    Avidan B; Melzer E; Keller N; Bar-Meir S
    Isr Med Assoc J; 2001 Mar; 3(3):163-5. PubMed ID: 11303370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rescue Therapy for Helicobacter pylori Eradication: A Randomized Non-Inferiority Trial of Amoxicillin or Tetracycline in Bismuth Quadruple Therapy.
    Chen Q; Zhang W; Fu Q; Liang X; Liu W; Xiao S; Lu H
    Am J Gastroenterol; 2016 Dec; 111(12):1736-1742. PubMed ID: 27670603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Randomized Controlled Trial Shows that both 14-Day Hybrid and Bismuth Quadruple Therapies Cure Most Patients with Helicobacter pylori Infection in Populations with Moderate Antibiotic Resistance.
    Tsay FW; Wu DC; Yu HC; Kao SS; Lin KH; Cheng JS; Wang HM; Chen WC; Sun WC; Tsai KW; Hsu PI
    Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28807915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term follow-up study of serum immunoglobulin G and immunoglobulin A antibodies after Helicobacter pylori eradication.
    Kato S; Furuyama N; Ozawa K; Ohnuma K; Iinuma K
    Pediatrics; 1999 Aug; 104(2):e22. PubMed ID: 10429140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bismuth-based triple therapy with bismuth subcitrate, metronidazole and tetracycline in the eradication of Helicobacter pylori: a randomized, placebo controlled, double-blind study.
    Veldhuyzen Van Zanten S; Farley A; Marcon N; Lahaie R; Archambault A; Hunt R; Bailey R; Owen D; Spénard J; Stiglick A; Aimola N; Colin P
    Can J Gastroenterol; 2000; 14(7):599-602. PubMed ID: 10978947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.